Dietary Naringenin Preserves Insulin Sensitivity and Grip Strength and Attenuates Inflammation but Accelerates Weight Loss in a Mouse Model of Cancer Cachexia
- 27 September 2021
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 65 (22) , 2100268-e2100268
Abstract
Scope: Cancer cachexia is characterized by the loss of skeletal muscle resulting in functional impairment, reduced quality of life and mortality. Naringenin, a flavonoid found in citrus fruits, improves insulin sensitivity and reduces inflammation and tumor growth in preclinical models. Therefore, the study hypothesizes that dietary supplementation of naringenin will improve insulin sensitivity, decrease inflammation, slow body weight loss, and delay tumor growth in a mouse model of cancer cachexia.Methods and Results: Mice are fed 2 wt% dietary naringenin before and during initiation of cancer cachexia using inoculated adenocarcinoma‐26 cells (C‐26). Food intake, body weight, body composition, muscle function, insulin tolerance, and inflammatory status are assessed. Although naringenin‐fed tumor‐bearing mice exhibit reductions in body weight and food intake earlier than control diet‐fed tumor‐bearing mice, dietary naringenin is protective against loss of muscle strength, and attenuates the onset of insulin resistance and markers of inflammation.Conclusions: Dietary supplementation of naringenin improves multiple aspects of metabolic disturbance and inflammation during cancer cachexia progression in [C‐26 tumor‐bearing] mice. However, the acceleration of anorexia and weight loss is also observed. These findings emphasize the link between inflammation and insulin resistance as a basis for understanding their roles in the pathogenesis of cancer cachexia.Keywords
Funding Information
- National Cancer Institute (NIHR21CA185140)
This publication has 65 references indexed in Scilit:
- Flavonoid Naringenin: A Potential Immunomodulator forChlamydia trachomatisInflammationMediators of Inflammation, 2013
- Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexiaDisease Models & Mechanisms, 2012
- The role of insulin resistance in the development of muscle wasting during cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2011
- Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexiaCancer Biology & Therapy, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin ResistanceDiabetes, 2009
- Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectinPhytotherapy Research, 2008
- Fruit and vegetable intake and esophageal cancer in a large prospective cohort studyInternational Journal of Cancer, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001